GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » TFBS Bioscience Inc (ROCO:6939) » Definitions » ROC %

TFBS Bioscience (ROCO:6939) ROC % : -10.15% (As of Jun. 2024)


View and export this data going back to 2023. Start your Free Trial

What is TFBS Bioscience ROC %?

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. TFBS Bioscience's annualized return on capital (ROC %) for the quarter that ended in Jun. 2024 was -10.15%.

As of today (2025-03-24), TFBS Bioscience's WACC % is 9.48%. TFBS Bioscience's ROC % is -7.18% (calculated using TTM income statement data). TFBS Bioscience earns returns that do not match up to its cost of capital. It will destroy value as it grows.


TFBS Bioscience ROC % Historical Data

The historical data trend for TFBS Bioscience's ROC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

TFBS Bioscience ROC % Chart

TFBS Bioscience Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROC %
0.14 2.56 11.44 -1.23

TFBS Bioscience Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
ROC % Get a 7-Day Free Trial 16.92 8.09 2.65 -2.77 -10.15

TFBS Bioscience ROC % Calculation

TFBS Bioscience's annualized Return on Capital (ROC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-4.453 * ( 1 - -2.83% )/( (314.5 + 430.19)/ 2 )
=-4.5790199/372.345
=-1.23 %

where

Invested Capital(A: Dec. 2022 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1363.402 - 39.518 - ( 1026.437 - max(0, 103.811 - 1113.195+1026.437))
=314.5

Invested Capital(A: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1448.042 - 38.507 - ( 979.345 - max(0, 84.879 - 1072.849+979.345))
=430.19

TFBS Bioscience's annualized Return on Capital (ROC %) for the quarter that ended in Jun. 2024 is calculated as:

ROC % (Q: Jun. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Dec. 2023 ) + Invested Capital (Q: Jun. 2024 ))/ count )
=-51.716 * ( 1 - -0.91% )/( (430.19 + 598.428)/ 2 )
=-52.1866156/514.309
=-10.15 %

where

Invested Capital(Q: Dec. 2023 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1448.042 - 38.507 - ( 979.345 - max(0, 84.879 - 1072.849+979.345))
=430.19

Invested Capital(Q: Jun. 2024 )
=Total Assets - Accounts Payable & Accrued Expense - Excess Cash
=Total Assets - Accounts Payable & Accrued Expense - ( Cash, Cash Equivalents, Marketable Securities - max(0, Total Current Liabilities - Total Current Assets+Cash, Cash Equivalents, Marketable Securities))
=1420.824 - 38.94 - ( 784.068 - max(0, 88.088 - 871.544+784.068))
=598.428

Note: The Operating Income data used here is two times the semi-annual (Jun. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


TFBS Bioscience  (ROCO:6939) ROC % Explanation

ROC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROIC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, TFBS Bioscience's WACC % is 9.48%. TFBS Bioscience's ROC % is -7.18% (calculated using TTM income statement data). TFBS Bioscience earns returns that do not match up to its cost of capital. It will destroy value as it grows.


Be Aware

Like ROE % and ROA %, ROC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


TFBS Bioscience ROC % Related Terms

Thank you for viewing the detailed overview of TFBS Bioscience's ROC % provided by GuruFocus.com. Please click on the following links to see related term pages.


TFBS Bioscience Business Description

Traded in Other Exchanges
N/A
Address
No. 103, Lane 169, Kang-ning Street, 3rd Floor, Xizhi District, New Taipei, TWN
TFBS Bioscience Inc is a Contract Research Organization (CRO) providing biological testing in Taiwan. Its services include viral vector manufacturing for cell and gene therapy products and biosafety testing and product release testing for cell and gene therapy products, vaccines, and biologic products.

TFBS Bioscience Headlines

No Headlines